n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Injury, Myocardial Reperfusion in 10 studies
N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the current study was to determine whether hypercholesterolemia affects the delayed sevoflurane preconditioning against myocardial ischemia-reperfusion (IR) injury and, if so, the underlying mechanism." | 7.78 | Hypercholesterolemia abrogates sevoflurane-induced delayed preconditioning against myocardial infarct in rats by alteration of nitric oxide synthase signaling. ( Chen, G; Ma, LL; Qian, LB; Wang, WN; Yan, M; Yang, MJ; Yu, J; Yu, LN; Zhang, FJ, 2012) |
| "The aim of the current study was to determine whether hypercholesterolemia affects the delayed sevoflurane preconditioning against myocardial ischemia-reperfusion (IR) injury and, if so, the underlying mechanism." | 3.78 | Hypercholesterolemia abrogates sevoflurane-induced delayed preconditioning against myocardial infarct in rats by alteration of nitric oxide synthase signaling. ( Chen, G; Ma, LL; Qian, LB; Wang, WN; Yan, M; Yang, MJ; Yu, J; Yu, LN; Zhang, FJ, 2012) |
| " This pre-treatment resulted in full protection of contractility, decreased production of iNOS and ADMA and normalized the bioavailability of NO in the I/R hearts." | 1.56 | A drug cocktail for protecting against ischemia-reperfusion injury. ( Bil-Lula, I; Krzywonos-Zawadzka, A; Sawicki, G; Wozniak, M, 2020) |
| " The present study demonstrated that iNOS-derived superoxide generation was reduced, and that the NO bioavailability was increased, by treatment with the NOS-cofactor, tetrahydrobiopterin (BH4), before I/R in the hearts isolated from diabetic rats." | 1.37 | Reversal of inducible nitric oxide synthase uncoupling unmasks tolerance to ischemia/reperfusion injury in the diabetic rat heart. ( Fujita, M; Ito, S; Iwasaka, T; Katano, T; Okazaki, T; Otani, H; Shimazu, T; Yoshioka, K, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krzywonos-Zawadzka, A | 1 |
| Wozniak, M | 1 |
| Sawicki, G | 1 |
| Bil-Lula, I | 1 |
| Chen, TH | 1 |
| Liao, FT | 1 |
| Yang, YC | 1 |
| Wang, JJ | 1 |
| Zhang, FJ | 1 |
| Ma, LL | 1 |
| Wang, WN | 1 |
| Qian, LB | 1 |
| Yang, MJ | 1 |
| Yu, J | 1 |
| Chen, G | 1 |
| Yu, LN | 1 |
| Yan, M | 1 |
| Arnaud, C | 1 |
| Godin-Ribuot, D | 2 |
| Bottari, S | 1 |
| Peinnequin, A | 1 |
| Joyeux, M | 1 |
| Demenge, P | 1 |
| Ribuot, C | 2 |
| Rosanio, S | 1 |
| Ye, Y | 1 |
| Atar, S | 1 |
| Rahman, AM | 1 |
| Freeberg, SY | 1 |
| Huang, MH | 1 |
| Uretsky, BF | 1 |
| Birnbaum, Y | 1 |
| Joyeux-Faure, M | 1 |
| Ramond, A | 1 |
| Béguin, PC | 1 |
| Belaïdi, E | 1 |
| Matsuhisa, S | 1 |
| Otani, H | 2 |
| Okazaki, T | 2 |
| Yamashita, K | 1 |
| Akita, Y | 1 |
| Sato, D | 1 |
| Moriguchi, A | 1 |
| Imamura, H | 1 |
| Iwasaka, T | 2 |
| Cross, HR | 1 |
| Murphy, E | 1 |
| Koch, WJ | 1 |
| Steenbergen, C | 1 |
| Shimazu, T | 1 |
| Yoshioka, K | 1 |
| Fujita, M | 1 |
| Katano, T | 1 |
| Ito, S | 1 |
| Liu, Y | 1 |
| Qu, Y | 1 |
| Wang, R | 1 |
| Ma, Y | 1 |
| Xia, C | 1 |
| Gao, C | 1 |
| Liu, J | 1 |
| Lian, K | 1 |
| Xu, A | 1 |
| Lu, X | 1 |
| Sun, L | 1 |
| Yang, L | 1 |
| Lau, WB | 1 |
| Gao, E | 1 |
| Koch, W | 1 |
| Wang, H | 1 |
| Tao, L | 1 |
10 other studies available for n-(3-(aminomethyl)benzyl)acetamidine and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
A drug cocktail for protecting against ischemia-reperfusion injury.
Topics: Amidines; Animals; Arginine; Benzylamines; Enzyme Inhibitors; Heart; Male; Matrix Metalloproteinase | 2020 |
Inhibition of inducible nitric oxide synthase ameliorates myocardial ischemia/reperfusion injury - induced acute renal injury.
Topics: Acute Kidney Injury; Amidines; Animals; Benzylamines; Biomarkers; Blood Pressure; Cytoprotection; Di | 2014 |
Hypercholesterolemia abrogates sevoflurane-induced delayed preconditioning against myocardial infarct in rats by alteration of nitric oxide synthase signaling.
Topics: Amidines; Anesthetics, Inhalation; Animals; Anti-Arrhythmia Agents; bcl-Associated Death Protein; Be | 2012 |
iNOS is a mediator of the heat stress-induced preconditioning against myocardial infarction in vivo in the rat.
Topics: Amidines; Animals; Benzylamines; Blotting, Western; Hot Temperature; Ischemic Preconditioning, Myoca | 2003 |
Enhanced cardioprotection against ischemia-reperfusion injury with combining sildenafil with low-dose atorvastatin.
Topics: Amidines; Animals; Atorvastatin; Benzylamines; Cardiotonic Agents; Drug Synergism; Heart; Heptanoic | 2006 |
Early pharmacological preconditioning by erythropoietin mediated by inducible NOS and mitochondrial ATP-dependent potassium channels in the rat heart.
Topics: Amidines; Animals; Benzylamines; Decanoic Acids; Enzyme Inhibitors; Erythropoietin; Heart; Hydroxy A | 2006 |
Angiotensin II type 1 receptor blocker preserves tolerance to ischemia-reperfusion injury in Dahl salt-sensitive rat heart.
Topics: Aldehydes; Amidines; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Benzylamines; D | 2008 |
Male and female mice overexpressing the beta(2)-adrenergic receptor exhibit differences in ischemia/reperfusion injury: role of nitric oxide.
Topics: Amidines; Animals; Benzylamines; Enzyme Inhibitors; Female; Male; Mice; Mice, Transgenic; Models, An | 2002 |
Reversal of inducible nitric oxide synthase uncoupling unmasks tolerance to ischemia/reperfusion injury in the diabetic rat heart.
Topics: Animals; Biopterins; Cyclic GMP; Diabetes Complications; Diabetes Mellitus, Experimental; Dithiothre | 2011 |
The alternative crosstalk between RAGE and nitrative thioredoxin inactivation during diabetic myocardial ischemia-reperfusion injury.
Topics: Acetophenones; Animals; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Free Radical Scavengers; | 2012 |